Prepulse inhibition (PPI) and reactivity of the acoustic startle response are widely used biobehavioral markers in psychopathology research. Previous studies have demonstrated that PPI and startle reactivity exhibit substantial within-site stability; however, between-site stability has not been established. In two separate consortia investigating biomarkers of early psychosis, traveling participants studies were carried out as a part of quality assurance procedures to assess the fidelity of data across sites. In the North American Prodromal Longitudinal Studies (NAPLS) consortium, eight normal participants traveled to each of the eight NAPLS sites and were tested twice at each site on the startle PPI paradigm. In preparation for a binational study, 10 healthy participants were assessed twice in both San Diego and Mexico City. Intraclass correlations between and within sites were significant for PPI and startle response parameters, confirming the reliability of startle measures across sites in both consortia. There were between-site differences in startle magnitude in the NAPLS study that did not appear to be related to methods or equipment. In planning multisite studies, it is essential to institute quality assurance procedures early and establish between-site reliability to assure comparable data across sites.
Introduction
Prepulse inhibition (PPI) and reactivity of the acoustic startle response are widely used translational biomarkers in psychopathological research. PPI is an index of sensorimotor gating and is used in animal and human studies to understand brain disorders such as schizophrenia and Tourette's disorder that are characterized by gating impairments in the neural substrates that underlie sensory information processing [1] . In the PPI paradigm, weak lead stimuli inhibit the startle response to intense, abrupt stimuli (acoustic, visual, tactile) [2] . PPI is typically reduced in individuals with schizophrenia [3] , stable with repeated within-site testing [4] [5] [6] [7] [8] [9] [10] , heritable [11, 12] , and associated with genes of relevance to psychosis [13, 14] , suggesting its utility as an endophenotype and as a vulnerability marker for psychosis risk [15] .
An increasing emphasis in schizophrenia research has been in the area of early detection and intervention. The use of biobehavioral markers such as PPI in the study of the prodromal phase of psychosis provides a means of not only identifying individuals at greatest risk for psychosis but also understanding neurodevelopmental abnormalities early in the course of illness that can contribute to better informed treatment [16] . Although it is possible to use empirically derived criteria for a prodromal psychosis syndrome [17] to identify individuals at increased risk of psychotic illness, the 2 year psychotic conversion rate is between 15-35% [18] , making it difficult to recruit a sufficient number of participants at any one site. Therefore, multisite studies are essential to attain sufficient statistical power to investigate the prodromal phase of illness.
However, for biomarkers such as PPI to be useful in multisite studies that are needed to increase statistical power, facilitate the identification of disease risk, increase the odds of finding uncommon genetic variation, or identification of relevant subgroups, the measures need to be stable with repeated assessment and reliable across sites [19] . Because differences in testing conditions and procedures across sites can introduce uncontrolled variance in experimental measures, it is essential to understand potential site differences and control variation across sites as much as possible. Although multisite studies have investigated PPI [19] , to our knowledge, there are no published reports of between-site reliability of startle measures using normal participants traveling between sites. This study investigated the within-site and between-site reliability of PPI and startle reactivity in two consortia designed to identify vulnerability markers in early psychosis: the North American Prodromal Longitudinal Studies (NAPLS) consortium and a University of California Institute for Mexico and the United States (UCMEXUS).
Materials and methods

Participants
Participants included (i) eight healthy individuals recruited from each of the eight NAPLS sites [Emory, Harvard, University of Calgary, University of California Los Angeles, University of California San Diego (UCSD), University of North Carolina, Yale, Zucker Hillside] (age 19-30 years, four men and four women) and (ii) 10 healthy individuals (age 28-38 years, four men and six women), recruited from the UCSD and the National Institute of Neurology and Neurosurgery (INNN) in Mexico City. All nine institutions received approval from their individual ethics committees for the study. Participants provided written informed consent after the procedures were fully explained. Participants were excluded if they had the following: any concomitant medical or neurological illness, current substance abuse or dependence (excluding nicotine), any Axis I disorders (per Structured Interview for DSM-IV), or positive family history of psychosis.
Acoustic startle paradigm
Equipment and procedures were identical at the eight NAPLS sites as well as between UCSD and INNN. Manuals with equipment setup, testing procedures, and instructions to participants were developed in English and Spanish (for INNN). A meeting was held in Boston October 2009 to train all NAPLS sites; UCSD staff visited the Mexico site in September 2009 to train INNN using the same procedures [20] .
Participants were screened for hearing impairment (> 45 dB, 1000 Hz). Smokers were allowed to smoke up to 30 min before startle testing to avoid nicotine withdrawal or intoxication. A customized startle-stimulus generating system (Grace Design Model m902 Amplifier and Neurobehavioral Systems Presentation Software) developed by the UCSD site was used for all sites. The sound was calibrated at all sites using a Quest Technologies 210 Sound Level Meter (Oconomowoc, Wisconsin, USA) and a custom-made PPI calibration session to ensure 70 dB for background noise and 115 dB for extended length startle bursts at each of the sites. Neurophysiologic recordings at NAPLS sites were performed using identical Biosemi systems and recording software (Biosemi, Amsterdam, the Netherlands). For the UCMEXUS study, data were recorded using NeuroScan equipment and software (NuAmps Digital EEG Amplifier; NeuroScan Labs, Sterling, Virginia, USA). Electrodes (Ag/AgCl) were placed below and at the outer canthus of the right eye with resistances less than 10 kO [20] . Startle stimuli were presented binaurally through identical headphones (TDH-39P) at all sites. A 70 dB [A] broadband background noise was used with a pulse (115 dB [A], 40 ms noise burst) presented either alone or following [30, 60, or 120 ms interstimulus interval (ISI)] a prepulse (86 dB [A], 20 ms noise burst). The paradigm began with a 5-min acclimation period, then five pulsealone stimuli followed by 30 trials consisting six trials each of the three prepulse conditions and 12 pulse-alone stimuli presented in a fixed, pseudorandom order. The paradigm ended with five more pulse-alone stimuli for a total of 40 trials. EMG activity for both consortia was analyzed at UCSD using Brain Vision Analyzer (Brain Vision LLC, Morrisville, North Carolina, USA) and highpass filtered at 28 Hz at 12 dB/oct. Waveforms were smoothed using a 40 Hz 24 dB/oct low-pass filter. All trials were manually inspected for artifacts. Startle data were analyzed using wave-form averaging for each of the four different trial types within each block, after applying baseline correction and rectification of the data. The magnitude of the peak startle response (the highest point relative to baseline between 30 and 120 ms after onset of startle stimulus) was determined. All participants demonstrated a robust startle response to the first block of startle stimuli; however, participants who demonstrated a relative lack of startle stimulus elicited eye blink to the second block of startle stimuli in any test session were excluded per established methods [20] . The following startle measures were examined: (i) reactivity, or the mean magnitude of response to pulse-alone stimuli, and (ii) PPI, the percentage of change in startle magnitude to prepulse + pulse versus pulse-alone trials [(pulse-prepulse + pulse)/pulse) Â 100]. The stability of the startle measures between and within sites was assessed using intraclass correlations (ICC; random consistency model) and repeated measures analysis of variance (ANOVA) design. All participants were tested twice at each site and traveled to the other sites within 3 months for NAPLS and within 1 year (mean 5.5 months) for UCMEXUS. The order of testing was balanced across sites in both studies with a specified order for NAPLS participants starting with the home site and within the ten participants who were included in the UCMEXUS study (five at UCSD first, five at INNN first). Table 1 , within-site ICCs of startle and PPI variables were significant across all reactivity and PPI conditions in both NAPLS and UCMEXUS (Table 1) . Between-site analyses were similarly performed comparing time 1 to time 1 and time 2 to time 2 across sites. All but the 30-ms PPI (P = 0.056) condition for UCMEXUS were significant. Finally, within-site and between-site ICCs were calculated using both sessions at each of the sites and all were significant. In repeated measures ANOVA of PPI (NAPLS: 8 sites Â 2 sessions Â 3 ISIs; UCMEXUS: 2 sites Â 2 sessions Â 3 ISIs) there were no statistical site [NAPLS: F(7,108) = 0.45, NS; UCMEXUS: F(1,9) = 0.51, NS] or session [NAPLS: F(1,108) = 0.72, NS; UCMEXUS: F(1,9) = 0.83, NS] main or interaction effects supporting the within-site and between-site reliability. In contrast, a repeated measures ANOVA of startle reactivity (NAPLS: 8 sitesÂ 2 timesÂ 3 blocks; UCMEXUS: 2 sites Â 2 times Â 3 blocks) revealed a significant site effect [F(7,28) = 2.46, P < 0.05] for the NAPLS study due to one site having greater startle amplitude relative to the other sites ( Fig. 1 ), but no session or interaction effects. When NAPLS site 4 was removed from the analysis, the significant site effect was no longer present [F(6,30) = 1.97, NS]. The site main effect for UCMEXUS [F (1, 9) = 0.48, NS] was nonsignificant as were session and interaction effects.
Results
As shown in
Discussion
This is the first report of between-site reliability of PPI and startle reactivity measured with traveling partici-pants. The present findings replicate previous studies that demonstrate within-site stability of startle measures in normal and schizophrenia spectrum participants [4] [5] [6] [7] [8] [9] [10] and extend these findings to demonstrate measurement comparability across laboratories in two separate multisite studies using two different types of equipment for neurophysiologic recording. It is likely that the standardization of equipment, protocols, training, analysis, and quality assurance procedures across sites contributed to the observed consistency of startle data.
Although startle reactivity was stable both within and between sites, significant site differences were observed in the NAPLS study driven by larger startle amplitude at one of the sites, prompting a review of equipment settings, stimulus calibration, ambient acoustic noise, electrical noise, placement of electrodes, participant instructions, and testing environment across sites. A decibel meter from UCSD was mailed to the site in question (site 4) to assure the loudness of the startle stimuli was accurate and consistent across sites. No methodological or equipment differences were identified. Individual participant data revealed that three participants had larger startle responses at site 4 (Fig. 2) , accounting for the site differences. One participant with a large startle response was first exposed to the startle stimuli at site 4, perhaps accounting for the larger response. Since each participant began their travels at their home site, it is unlikely that order effects account for the observed differences. Thus, despite institution of careful quality assurance procedures, identical participants, methodology, and equipment, site differences still occur and need to be examined and controlled for in biomarker studies. Future analyses of NAPLS consortium data will continue to examine site differences in reactivity and site will be used as a between-participants factor.
A limitation of the two studies is the relatively small sample size in each (NAPLS included eight participants tested at eight sites and UCMEXUS included 10 participants tested at two sites). The sample sizes, however, are consistent with the few traveling participants Table 1 Intraclass correlations (random consistency model) of startle reactivity and prepulse inhibition within and between sites in the NAPLS and UCMEXUS studies studies performed to establish reliability of neuroimaging measures across sites [21, 22] . Although future between-site biomarker reliability studies should ideally use more participants, sending multiple participants to different cities and countries for multiple testing sessions obviously presents financial and logistical challenges.
Conclusion
In planning multisite biomarker studies, it is essential to institute standardized quality assurance procedures before data collection of targeted research samples. The use of identical equipment, training, and similar testing environments appears to be useful to minimize sources of crosssite variance in electrophysiological studies. The observed reliability of startle measures across laboratories provides support for the utility of these measures as biomarkers and endophenotypes in large multisite studies. Investigation and statistical control of potential site differences is essential in any multisite biomarker study. Site differences in startle reactivity were evident in the North American Prodromal Longitudinal Studies consortium. Data represents estimated marginal means that collapsed two test sessions at each site. Individual traveling participants data from the North American Prodromal Longitudinal Studies consortium demonstrates that three participants accounted for the observed site differences. Data represents estimated marginal means that collapse both test sessions and three blocks of startle magnitude in response to pulse-alone stimuli.
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